13 results
8-K
EX-2.1
TPST
Tempest Therapeutics Inc
29 Mar 21
Tempest and Millendo Announce Proposed Merger Agreement
7:29am
425
EX-2.1
TPST
Tempest Therapeutics Inc
29 Mar 21
Business combination disclosure
7:27am
8-K
EX-2.1
TPST
Tempest Therapeutics Inc
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
425
EX-2.1
TPST
Tempest Therapeutics Inc
1 Nov 18
Business combination disclosure
5:00pm
8-K
EX-2.2
x7urwiyr
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.3
8nyi7bo3y7
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.1
m9kil yhd79sb4
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.4
f1su5iyurloks
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.3
ggvmn
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.1
4dqqs xgpq
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.2
7yosdj3e8hamw5n
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.4
feqj6sv 2262k
9 Aug 18
Business combination disclosure
5:17pm
- Prev
- 1
- Next